Vanda Pharmaceuticals
VNDA
#7970
Rank
ยฃ0.26 B
Marketcap
ยฃ4.39
Share price
-2.68%
Change (1 day)
30.66%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -ยฃ91.26 Million

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.21 Billion. In 2024 the company made an earning of -ยฃ30.79 Million a decrease over its 2023 earnings that were of -ยฃ10.57 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ91.26 Million196.39%
2024 -ยฃ30.79 Million191.43%
2023 -ยฃ10.57 Million-320.45%
2022 ยฃ4.79 M-84.99%
2021 ยฃ31.92 M54.8%
2020 ยฃ20.62 M19.42%
2019 ยฃ17.27 M4.93%
2018 ยฃ16.46 M-228.6%
2017 -ยฃ12.8 Million-8.98%
2016 -ยฃ14.07 Million-53.79%
2015 -ยฃ30.43 Million-30.18%
2014 -ยฃ43.59 Million173.08%
2013 -ยฃ15.96 Million-25.33%
2012 -ยฃ21.38 Million163.61%
2011 -ยฃ8.11 Million-221.15%
2010 ยฃ6.69 M-124.53%
2009 -ยฃ27.29 Million-29.44%
2008 -ยฃ38.67 Million-36.2%
2007 -ยฃ60.61 Million21.81%
2006 -ยฃ49.76 Million170.55%
2005 -ยฃ18.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.67 B-21,553.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ11.95 B-13,134.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ8.01 B-8,846.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ23.56 B-25,803.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ9.95 B-10,960.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ7.26 B-8,025.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-ยฃ2.13 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA